UMass Memorial entities ordered to pay $230K fine for data breaches

The Massachusetts Office of the Attorney General announced on Thursday, Sept. 20, that UMass Memorial Medical Group, Inc. and UMass Memorial Medical Center, Inc. have been ordered to pay $230,000 following two separate data breaches that exposed the personal health information of more than 15,000 people.

According the Massachusetts AG’s office, two former employees improperly accessed the personal and protected health information of patients for fraudulent purposes during two separate breaches. The office also accused the entities of violating the Consumer Protection Act, the Massachusetts Data Security Law and HIPAA for failing to “properly protect patients’ information.”

“Investigations by the AG’s Office revealed that the breaches exposed patient information including names, addresses, social security numbers, clinical information and health insurance information,” a statement said.

“The AG’s lawsuit alleges that UMass Memorial Medical Group Inc. and UMass Memorial Medical Center Inc. knew of these employees’ misconduct but failed to properly investigate complaints related to these breaches, discipline the employees involved in a timely manner, or take other steps to safeguard the information.”

Along with the fine, the UMass entities will be required to conduct employee background checks, train employees on how to properly handle patient information, identify and solve potential data security issues and quickly investigate suspected improper access to patient information.

They will also be required to hire an independent third-party firm to review of its data security.

""

Danielle covers Clinical Innovation & Technology as a senior news writer for TriMed Media. Previously, she worked as a news reporter in northeast Missouri and earned a journalism degree from the University of Illinois at Urbana-Champaign. She's also a huge fan of the Chicago Cubs, Bears and Bulls. 

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.